197 related articles for article (PubMed ID: 6685702)
1. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):382-4. PubMed ID: 6685702
[TBL] [Abstract][Full Text] [Related]
2. Relapse rates in lepromatous leprosy according to treatment regularity.
Almeida JG; Jesudasan K; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):16-20. PubMed ID: 3519802
[TBL] [Abstract][Full Text] [Related]
3. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
4. Response to dapsone (DDS) monotherapy in leprosy patients of Gudiyatham Taluk, South India: comparison between the 1960s and the 1970s.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):378-8. PubMed ID: 6685701
[TBL] [Abstract][Full Text] [Related]
5. Results of long-term domiciliary dapsone (DDS) monotherapy for lepromatous leprosy in Gudiyatham Taluk, South India.
Almeida JG; Christian M; Chacko CJ
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):385-6. PubMed ID: 6685703
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
Balraj V; Jesudasan K; Chacko CJ; Christian M; Taylor PM; Fritschi EP; Job CK
Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):397-401. PubMed ID: 7193654
[TBL] [Abstract][Full Text] [Related]
7. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
8. Trends in leprosy over fifty years in Gudiyatham Taluk, Vellore, Tamil Nadu.
Norman G; Raja Samuel Bhushanam JD; Samuel P
Indian J Lepr; 2006; 78(2):167-85. PubMed ID: 16927851
[TBL] [Abstract][Full Text] [Related]
9. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
10. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
12. Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India.
Daniel E; Koshy S; Joseph GA; Rao PS
Indian J Ophthalmol; 2003 Jun; 51(2):155-9. PubMed ID: 12831146
[TBL] [Abstract][Full Text] [Related]
13. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
[TBL] [Abstract][Full Text] [Related]
14. Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):161-72. PubMed ID: 1522358
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of drug regimen in lepromatous leprosy--II.
Ramu G; Sreevatsa
Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the self administration of DDS in Gudiyatham Taluk.
Jesudasan K; George B; Chacko CJ; Taylor PM; Kurian PV; Job CK
Lepr India; 1976 Oct; 48(4 Suppl):668-76. PubMed ID: 1026802
[TBL] [Abstract][Full Text] [Related]
17. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
Katoch K; Katoch VM; Natrajan M; Sreevatsa ; Gupta UD; Sharma VD; Shivanavar CT
Vaccine; 2004 Sep; 22(27-28):3649-57. PubMed ID: 15315844
[TBL] [Abstract][Full Text] [Related]
18. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.
Chen XS; Li WZ; Jiang C; Ye GY
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):371-8. PubMed ID: 10700910
[TBL] [Abstract][Full Text] [Related]
19. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
20. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
Norman G; Joseph G; Richard J
Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
